Profile data is unavailable for this security.
About the company
SinoMab BioScience Ltd is a Hong Kong-based biopharmaceutical company mainly dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases. The Company primarily develops mAb-based biologics and new chemical entities (NCE). The Company’s product SM03 is a mAb for the treatment of rheumatoid arthritis (RA). The Company is developing drugs for the treatment of RA, systemic lupus erythematosus (SLE), asthma, pemphigus, sjogren’s syndrome (SS) and other immunological diseases.
- Revenue in HKD (TTM)1.47m
- Net income in HKD-262.46m
- Incorporated2001
- Employees215.00
- LocationSinoMab BioScience LtdUnits 303 and 305 to 307No.15 Science Park West AvenueHong Kong Hong KongHKG
- Phone+852 34269833
- Websitehttps://www.sinomab.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hbm Holdings Ltd | 698.69m | 177.96m | 991.85m | 177.00 | 5.33 | 1.01 | 4.64 | 1.42 | 0.2421 | 0.2421 | 0.952 | 1.28 | 0.3886 | 3.90 | 3.01 | 3,947,392.00 | 9.88 | -54.61 | 14.13 | -66.04 | 97.73 | 97.81 | 25.43 | -400.28 | 3.28 | 6.98 | 0.3556 | -- | 120.13 | 127.06 | 116.61 | -- | -12.62 | -- |
| Zhongzhi Pharmaceutical Holdings Ltd | 2.21bn | 175.73m | 1.05bn | 2.64k | 5.88 | 0.9308 | 3.66 | 0.4761 | 0.2075 | 0.2075 | 2.61 | 1.31 | 1.12 | 2.53 | 10.54 | 837,277.30 | 8.95 | 7.69 | 14.15 | 11.75 | 59.73 | 60.44 | 8.01 | 6.73 | 0.894 | -- | 0.1424 | 42.46 | 12.26 | 12.41 | 53.00 | 13.86 | 17.65 | 3.22 |
| VIVA Biotech Holdings | 2.33bn | -125.35m | 1.08bn | 2.08k | -- | 0.269 | 8.98 | 0.4644 | -0.0638 | -0.0638 | 1.20 | 1.86 | 0.2805 | 4.84 | 5.21 | 1,120,417.00 | -1.30 | -1.39 | -1.79 | -1.68 | 34.26 | 34.81 | -4.63 | -5.44 | 1.15 | 1.00 | 0.3412 | -- | -9.42 | 59.31 | 78.03 | -- | 31.98 | -- |
| Jacobson Pharma Corporation Ltd | 1.47bn | 210.24m | 1.18bn | 1.72k | 5.39 | 0.4925 | 3.35 | 0.804 | 0.1095 | 0.1391 | 0.7644 | 1.20 | 0.3311 | 2.47 | 6.37 | 851,885.10 | 4.74 | 4.30 | 5.76 | 5.57 | 42.27 | 41.25 | 14.32 | 13.73 | 1.73 | 5.33 | 0.2382 | 40.62 | 15.79 | -0.1401 | 1.31 | -3.05 | 24.06 | 4.10 |
| Ascletis Pharma Inc | 61.10m | -156.23m | 1.20bn | 219.00 | -- | 0.4908 | -- | 19.64 | -0.1468 | -0.1468 | 0.0569 | 2.42 | 0.022 | 2.30 | 3.86 | 278,993.50 | -5.62 | -6.43 | -5.91 | -6.64 | 45.92 | 35.67 | -255.70 | -243.38 | 16.54 | -6.09 | 0.0036 | -- | 4.63 | -19.39 | 54.04 | -- | -20.44 | -- |
| Essex Bio-Technology Ltd | 1.71bn | 275.26m | 1.36bn | 1.48k | 5.10 | 0.7051 | 4.05 | 0.7948 | 0.4689 | 0.4689 | 2.87 | 3.39 | 0.6161 | 2.28 | 3.35 | 1,152,300.00 | 9.94 | 11.20 | 13.21 | 14.73 | 90.20 | 86.01 | 16.13 | 19.77 | 1.46 | -- | 0.1326 | 16.16 | 29.51 | 7.72 | 22.11 | 3.56 | 7.29 | 7.39 |
| Dawnrays Pharmaceutical (Holdings) Ltd | 1.24bn | 351.94m | 1.73bn | 1.14k | 4.91 | 0.5598 | 3.82 | 1.39 | 0.2341 | 0.2341 | 0.8271 | 2.05 | 0.3156 | 2.31 | 6.37 | 1,087,267.00 | 8.85 | 9.89 | 11.36 | 12.49 | 54.60 | 56.69 | 28.03 | 27.89 | 2.26 | 28.89 | 0.0405 | 35.33 | -9.90 | 3.94 | -8.95 | 1.41 | 63.92 | 2.00 |
| SinoMab Bioscience Ltd | 1.47m | -262.46m | 1.75bn | 215.00 | -- | 5.19 | -- | 1,185.39 | -0.2578 | -0.2578 | 0.0015 | 0.3083 | 0.0015 | -- | -- | 6,854.04 | -26.20 | -24.62 | -32.50 | -27.72 | 30.92 | -- | -17,810.33 | -4,451.74 | -- | -11.48 | 0.604 | -- | -- | -- | 14.45 | -- | 106.81 | -- |
| Cryofocus Medtech Shanghai Co Ltd | 44.21m | -105.24m | 1.90bn | 392.00 | -- | 10.89 | -- | 42.94 | -0.4401 | -0.4401 | 0.1849 | 0.729 | -- | -- | -- | 112,776.90 | -- | -- | -- | -- | 75.83 | -- | -258.23 | -- | 4.08 | -- | 0.0597 | -- | 50.83 | -- | 13.13 | -- | -- | -- |
| Golden Throat Holdings Group Co Ltd | 1.04bn | 270.07m | 2.33bn | 869.00 | 8.62 | 1.39 | 7.46 | 2.24 | 0.3653 | 0.3653 | 1.40 | 2.26 | 0.4181 | 4.82 | 1.85 | 1,194,336.00 | 10.88 | 11.00 | 15.85 | 15.63 | 72.57 | 72.79 | 26.02 | 24.67 | 2.48 | 34.74 | 0.21 | 83.15 | -3.09 | 6.73 | -11.04 | 19.61 | -32.13 | 38.94 |
| Cutia Therapeutics | 148.57m | -2.12bn | 2.34bn | 298.00 | -- | 1.61 | -- | 15.76 | -6.97 | -6.97 | 0.4887 | 4.79 | -- | -- | -- | 498,571.20 | -- | -- | -- | -- | 51.60 | -- | -1,426.91 | -- | 5.38 | -- | 0.153 | -- | 1,110.83 | -- | -253.30 | -- | -- | -- |
Data as of Jul 26 2024. Currency figures normalised to SinoMab BioScience Ltd's reporting currency: Hong Kong Dollar HKD
